AJP - Lung Columbus Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol (March 11, 2005). doi:10.1152/ajplung.00003.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/2/L176    most recent
00003.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, F.
Right arrow Articles by Lum, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, F.
Right arrow Articles by Lum, H.
Submitted on January 4, 2005
Accepted on March 4, 2005

Lysophosphatidylcholine Increases Endothelial Permeability: Role of PKC{alpha} and RhoA Cross-talk

Fei Huang1, Papasani V Subbaiah2, Oksana Holian3, Jihang Zhang1, Arnold Johnson4, Nancy Gertzberg4, and Hazel Lum1*

1 Department of Pharmacology, Rush University Medical Center, Chicago, IL, USA
2 Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA
3 Department of Medicine, John H. Stroger Hospital of Cook County, Chicago, IL, USA
4 Research Service, Stratton Veterans Affairs Medical Center, Albany, NY, USA

* To whom correspondence should be addressed. E-mail: hlum{at}rush.edu.

Lysophosphatidylcholine (LPC) is a bioactive pro-inflammatory lipid which can be generated by pathological activities. We investigated the hypothesis that LPC signals increase of endothelial permeability. Stimulation of human dermal microvascular endothelial cells and bovine pulmonary microvascular endothelial cells with LPC (10 - 50 µM) induced decreases (within min) in transendothelial electrical resistance and increase of endothelial permeability. LPC activated (within 5 min) membrane-associated PKC phosphotransferase activity in the absence of translocation. Affinity-binding analysis indicated that LPC induced increases (also by 5 min) of GTP-bound RhoA, but not Rac1 nor Cdc42. By 60 min, both signaling pathways decreased towards baseline. Inhibition of RhoA with C3 transferase inhibited ~50% of LPC-induced resistance decrease. Pretreatment with PKC inhibitor GO6983 (concentrations selective for classic PKCs), PMA-induced depletion of PKC{alpha}, and transfection of antisense PKC{alpha} oligonucleotide each prevented 40 - 50% of the LPC-induced resistance decrease. Furthermore, these three PKC inhibition strategies inhibited 60 - 80% of the LPC-induced GTP-bound RhoA. These results show that LPC directly impairs the endothelial barrier function that was dependent, at least in part, on cross-talk of PKC{alpha} and RhoA signals. The evidence indicates that elevated LPC levels can contribute to the activation of a pro-inflammatory endothelial phenotype.




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Guo, D. Daines, J. Tang, Q. Shen, R. M. Perrin, Y. Takada, S. Y. Yuan, and M. H. Wu
Fibrinogen-{gamma} C-Terminal Fragments Induce Endothelial Barrier Dysfunction and Microvascular Leak via Integrin-Mediated and RhoA-Dependent Mechanism
Arterioscler Thromb Vasc Biol, March 1, 2009; 29(3): 394 - 400.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. Qiao, O. Holian, B.-S. Lee, F. Huang, J. Zhang, and H. Lum
Phosphorylation of GTP dissociation inhibitor by PKA negatively regulates RhoA
Am J Physiol Cell Physiol, November 1, 2008; 295(5): C1161 - C1168.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. R. Klinger, J. D. Murray, B. Casserly, D. F. Alvarez, J. A. King, S. S. An, G. Choudhary, A. N. Owusu-Sarfo, R. Warburton, and E. O. Harrington
Rottlerin causes pulmonary edema in vivo: a possible role for PKC{delta}
J Appl Physiol, December 1, 2007; 103(6): 2084 - 2094.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
P. J. Ojala, T. E. Hirvonen, M. Hermansson, P. Somerharju, and J. Parkkinen
Acyl chain-dependent effect of lysophosphatidylcholine on human neutrophils
J. Leukoc. Biol., December 1, 2007; 82(6): 1501 - 1509.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. C. White, P. Rastogi, and J. McHowat
Lysoplasmenylcholine increases neutrophil adherence to human coronary artery endothelial cells
Am J Physiol Cell Physiol, November 1, 2007; 293(5): C1467 - C1471.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Qiao, F. Huang, R. P. Naikawadi, K. S. Kim, T. Said, and H. Lum
Lysophosphatidylcholine impairs endothelial barrier function through the G protein-coupled receptor GPR4
Am J Physiol Lung Cell Mol Physiol, July 1, 2006; 291(1): L91 - L101.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Pulinilkunnil and B. Rodrigues
Cardiac lipoprotein lipase: Metabolic basis for diabetic heart disease
Cardiovasc Res, February 1, 2006; 69(2): 329 - 340.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. Mehta
Lysophosphatidylcholine: an enigmatic lysolipid
Am J Physiol Lung Cell Mol Physiol, August 1, 2005; 289(2): L174 - L175.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.